1. Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R
- Author
-
David L. Brautigan, Jason A. Papin, Mark E. Smolkin, Sudhir Chowbina, Craig L. Slingluff, Amber L. Shada, and Kerrington R. Molhoek
- Subjects
Cancer Research ,biology ,Cell growth ,Melanoma ,Dermatology ,medicine.disease ,Receptor tyrosine kinase ,Cell biology ,Oncology ,Fibroblast growth factor receptor ,Cell culture ,biology.protein ,medicine ,Receptor ,Autocrine signalling ,neoplasms ,Insulin-like growth factor 1 receptor - Abstract
Melanomas depend on autocrine signals for proliferation and survival; however, no systematic screen of known RTKs has been performed to identify which autocrine signaling pathways are activated in melanoma. Here we performed a comprehensive analysis of 42 receptor tyrosine kinases (RTKs) in 6 individual human melanoma tumor specimens as well as 17 melanoma cell lines, some of which were derived from the tumor specimens. We identified 5 RTKs that were active in almost every one of the melanoma tissue specimens and cell lines, including two previously unreported receptors, IGF1R and MSPR, in addition to three receptors (VEGFR, FGFR and HGFR) known to be autocrine activated in melanoma. We show by real time quantitative PCR that all melanoma cell lines expressed genes for the RTK ligands HGF, IGF1 and MSP. Addition of antibodies to either IGF1 or HGF, but not to MSP, to the culture medium blocked melanoma cell proliferation, and even caused net loss of melanoma cells. Antibody addition deactivated IGF1R and HGFR receptors, as well as MAPK signaling. Thus, IGF1 is a new growth factor for autocrine driven proliferation of human melanoma in vitro. Our results suggest that IGF1-IGF1R autocrine pathway in melanoma is a possible target for therapy in human melanomas.
- Published
- 2011